Clinical trial
Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients
NCT00477516 · James B. Wetmore, MD, Other · Completed
Key facts
| NCT number | NCT00477516 |
|---|---|
| Title | Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients |
| Official title | Determination of FDF-23 Levels in Non-suppressible PTH Secretion and the Influence of Inflammation on Fetuin A Levels During Hemodialysis Treatment |
| Lead sponsor | James B. Wetmore, MD, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | End-Stage Renal Disease |
| Intervention type | Procedure |
| Interventions | exposure to a high-calcium dialysate bath |
| Enrollment | 18 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | May 23, 2007 |
| Last update posted | Jun 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: